New molecular causes of brain cancer and leukemia.

In Brain Cancer, Brain Science, Genetics by Brainy Days Ahead

According to one of the researchers, “with the identification of the molecular modes of action that contribute to cancer in patients carrying IDH1/2 mutations it is now possible to consider personalized treatment to potentially improve therapeutic response.” IDH1/2 mutations refers to the IDH1 gene on chromosome 2. We are all geneticists now.